跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
羅 力瑋
教授
醫學系內科學科
電子郵件
lwlo
vghtpe.gov
tw
網站
https://cv.nycu.edu.tw/?action=member&id=28
h-index
h10-index
h5-index
10064
引文
55
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
3937
引文
34
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
613
引文
12
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2006
2026
每年研究成果
概覽
指紋
網路
研究成果
(426)
類似的個人檔案
(6)
指紋
查看啟用 Li-Wei Lo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Atrial Fibrillation
94%
Catheter Ablation
67%
Paroxysmal Atrial Fibrillation
40%
Atrial Fibrillation Ablation
36%
Ablation
32%
Atrial Fibrillation Patient
30%
Persistent Atrial Fibrillation
29%
Ventricular Arrhythmia
22%
Pulmonary Vein Isolation
21%
Atrial Substrate
18%
CHA2DS2-VASc Score
15%
Arrhythmogenic Right Ventricular Cardiomyopathy
15%
Left Atrium
13%
National Cohort Study
11%
Electrophysiological Activity
11%
Pulmonary Vein
11%
95% Confidence Interval
10%
Sinus Rhythm
10%
Substrate Properties
10%
Hazard Ratio
10%
Left Atrial Function
10%
Electrogram
9%
Atrial Arrhythmias
9%
Heart Failure
8%
Ablation Outcomes
8%
Taiwan
8%
Ventricular Tachycardia
7%
Atrial Tachycardia
7%
Clinical Outcomes
7%
Radiofrequency Catheter Ablation
7%
Dominant Frequency
7%
Arrhythmia
7%
Ischemic Stroke
7%
Oral Anticoagulants
7%
Atrium
7%
Right Ventricular Outflow Tract
6%
Renal Denervation
6%
Right Atrium
6%
Structural Remodeling
6%
Ablation Therapy
6%
New-onset Atrial Fibrillation
6%
Superior Vena Cava
6%
Stroke Risk
6%
Complex Fractionated Atrial Electrograms
6%
Sudden Cardiac Death
6%
Activation Time
5%
Clinical Characteristics
5%
Drug Refractory
5%
Non-vitamin K Antagonist Oral Anticoagulants
5%
Left Atrial Diameter
5%
Medicine and Dentistry
Atrial Fibrillation
100%
Ablation
76%
Recurrent Disease
33%
Paroxysmal Atrial Fibrillation
29%
Pulmonary Vein Isolation
26%
Heart Ventricle Arrhythmia
22%
Ventricular Tachycardia
21%
Pulmonary Vein
18%
Electrography
16%
Arrhythmogenic Right Ventricular Dysplasia
14%
Left Atrium
13%
Apoplexy
13%
Atrial Fibrillation Ablation
12%
CHA2DS2-VASc Score
11%
Supraventricular Tachycardia
11%
Ventricular Outflow Tract
10%
Persistent Atrial Fibrillation
10%
Long-Term Outcome
10%
Sinus Rhythm
9%
Ablation Therapy
9%
Cardiac Dysrhythmia
9%
Electrocardiogram
8%
Cohort Analysis
8%
Myocardial Disease
8%
Hazard Ratio
8%
Cardiovascular System
7%
Atrial Flutter
7%
Premature Ventricular Contraction
7%
Congestive Heart Failure
7%
Antithrombotic
7%
Endocardium
6%
Brain Ischemia
6%
Atrium
6%
Risk Stratification
6%
Atrial Electrogram
6%
Superior Vena Cava
6%
Electrocardiography
6%
Heart Atrium Arrhythmia
5%
Tachyarrhythmia
5%
Sudden Cardiac Death
5%
Radiofrequency Ablation
5%
